CRA study materials
CRA study resources

CRA (Other exams) cheat sheet

CRA · Keep the key ideas within reach.

Quick reference

Project Development and Management

  • Project lifecycle phases: initiation (concept/idea), planning (proposal development), execution (award management), monitoring/controlling (progress reporting), and closeout (final reports and deliverables).

  • A work breakdown structure (WBS) decomposes deliverables into manageable work packages; each package should be assignable to a single owner and estimable in cost and duration.

  • Critical path method (CPM): the longest sequence of dependent tasks determines minimum project duration; any delay on the critical path delays the entire project.

  • Earned Value Management (EVM) formulas: Cost Variance (CV) = EV - AC; Schedule Variance (SV) = EV - PV; Cost Performance Index (CPI) = EV / AC; Schedule Performance Index (SPI) = EV / PV.

  • SMART objectives: Specific, Measurable, Achievable, Relevant, Time-bound. Each objective should map to at least one deliverable and one performance indicator.

  • Risk register elements: risk description, probability, impact, risk score (probability x impact), mitigation strategy, owner, and trigger/early warning indicator.

  • Stakeholder analysis matrix: power/interest grid classifies stakeholders as manage closely (high power, high interest), keep satisfied (high power, low interest), keep informed (low power, high interest), monitor (low power, low interest).

  • Gantt charts display task durations and dependencies; PERT charts (network diagrams) show task sequencing and can calculate expected time = (optimistic + 4 x most likely + pessimistic) / 6.

  • Change control process: request, impact analysis (scope, schedule, budget), approval by authorized official, implementation, and documentation in the change log.

Quick reference

Pre-Award Research Administration

  • Funding opportunity announcement (FOA) review: confirm eligibility, required cost share, page limits, submission deadline, and required registrations (e.g., SAM.gov, Grants.gov, institutional profile).

  • Proposal budget categories typically include personnel (salary + fringe), equipment (items ≥ $5,000 with useful life > 1 year, per federal definition), supplies, travel, consultants, subawards, and indirect costs (F&A).

  • Facilities and Administrative (F&A) cost rate: negotiated with the federal cognizant agency; applied to a modified total direct cost (MTDC) base that typically excludes equipment, capital expenditures, patient care, rental costs, tuition, scholarships, and subaward amounts beyond the first $25,000.

  • Cost sharing (matching): must be verifiable from recipient records, not paid by another federal award (unless authorized by statute), and documented in the proposal and award budget.

  • Proposal routing: internal review and sign-off by authorized organizational representative (AOR) and principal investigator (PI) before submission; verify conflict of interest disclosures and institutional approvals (IRB, IACUC, biosafety).

  • Just-in-time (JIT) information: some sponsors request additional documentation (e.g., other support, IRB approval) after peer review but before award; failure to submit can delay or preclude award.

  • Subrecipient vs. contractor determination: subrecipient creates or carries out a portion of the program (programmatic decision-making, may publish); contractor provides goods/services within normal business operations (no programmatic involvement).

  • Budget justification: narrative explaining and justifying each cost line; must align with the proposal narrative and sponsor guidelines; include basis of estimate (e.g., % effort, hourly rates, quotes).

Quick reference

Post-Award Research Administration

  • Notice of Award (NOA) review: confirm award amount, period of performance, terms and conditions, reporting deadlines, and any special restrictions (e.g., prior approval requirements).

  • Prior approval requirements: changes in PI, scope of work, significant rebudgeting (typically >10% of total budget), carryover of unobligated balances, and no-cost extensions often require sponsor approval.

  • Allowable costs: must be reasonable, allocable, consistently treated, and conform to sponsor terms and institutional policy (federal cost principles: 2 CFR 200 Subpart E).

  • Effort reporting: certify actual effort expended on sponsored projects; committed effort cannot be reduced without prior approval; effort must be documented and reconciled with payroll.

  • Cost transfers: must be timely (often within 90 days of original charge or before final financial report), fully documented, and justified; late transfers are scrutinized and may be disallowed.

  • Progress and final reports: submit technical reports (e.g., Research Performance Progress Report - RPPR) and financial reports (e.g., Federal Financial Report - FFR) by deadlines; final reports due typically within 90-120 days after period of performance ends.

  • No-cost extension (NCE): extends the period of performance without additional funds; may be approved by the institution (one-time) or require sponsor approval depending on terms; must be requested before the award expires.

  • Property management: equipment acquired under an award must be tracked, maintained, and disposed of per sponsor and institutional rules; title may vest with the recipient subject to conditions.

Quick reference

Financial Management

  • Allowability test: a cost is allowable if it is reasonable, allocable, consistently treated, and compliant with sponsor terms, institutional policy, and applicable regulations (e.g., 2 CFR 200).

  • Direct costs: can be specifically identified with a particular project (e.g., project personnel, project-specific supplies). Indirect costs: incurred for common objectives and cannot be easily assigned to a single project (e.g., facilities, administrative salaries).

  • MTDC (Modified Total Direct Cost) base: total direct costs minus equipment, capital expenditures, patient care, rental costs, tuition, scholarships/fellowships, and subaward amounts over $25,000.

  • Cost allocation: costs shared among multiple projects must be allocated using a documented, consistent, and reasonable method (e.g., proportional benefit, effort percentages).

  • Unallowable costs: examples include alcohol, entertainment, fines and penalties, lobbying, bad debts, contributions, and certain advertising; these cannot be charged to federal awards.

  • Financial reporting: Federal Financial Report (FFR/SF-425) reports cumulative cash receipts and expenditures; due typically 90 days after the end of the reporting period.

  • Drawdowns and cash management: recipients should minimize the time between drawdown of federal funds and disbursement (generally within 30 days); interest earned on advanced federal funds may be subject to remittance.

  • Closeout: reconcile accounts, submit final financial and technical reports, resolve outstanding obligations, and return any unexpended balance if required by the award terms.

Quick reference

Compliance and Regulatory Affairs

  • Human subjects research: requires Institutional Review Board (IRB) approval before initiation; informed consent must be obtained unless waived; continuing review and adverse event reporting required per IRB policy.

  • Animal research: requires Institutional Animal Care and Use Committee (IACUC) approval; adherence to the Animal Welfare Act and Public Health Service Policy; protocol modifications need prior approval.

  • Conflict of Interest (COI): investigators must disclose significant financial interests (e.g., >$5,000 or equity interest) that could affect research; institutions must manage, reduce, or eliminate conflicts.

  • Responsible Conduct of Research (RCR): training in data management, authorship, plagiarism, peer review, conflict of interest, and research misconduct; required for certain federal awards (e.g., NSF, NIH).

  • Export controls: research involving controlled technology, international collaborators, or restricted countries may require export licenses or license exceptions; fundamental research exclusion may apply.

  • Data management and sharing: many sponsors require a data management and sharing plan; data should be made accessible while protecting privacy and confidentiality (e.g., HIPAA, FERPA).

  • Research misconduct: fabrication, falsification, or plagiarism (FFP); institutions must have policies and procedures for reporting, investigating, and adjudicating allegations.

  • Clinical trial registration and reporting: applicable clinical trials must be registered on ClinicalTrials.gov and results submitted within specified timelines (e.g., 12 months after completion).

Quick reference

Professional Ethics and Conduct

  • Research integrity principles: honesty, objectivity, openness, accountability, fairness, and stewardship of resources; these guide conduct in proposal development, execution, and reporting.

  • Authorship: based on substantial contributions to conception, design, acquisition, analysis, or interpretation; drafting or revising; final approval; and accountability; ghost and gift authorship are unethical.

  • Plagiarism: using another's ideas, words, or data without attribution; includes self-plagiarism (reusing one's own prior work without citation) and misrepresentation of sources.

  • Data integrity: retain raw data and records for the period required by sponsor and institution (often 3 years after final report, longer for clinical trials); do not fabricate, falsify, or selectively report.

  • Conflict of interest management: disclose financial interests; recuse from decisions where a conflict exists; institutional review and management plans must be followed.

  • Mentor-mentee responsibilities: mentors should provide training, supervision, and career guidance; mentees should communicate openly and adhere to research standards.

  • Peer review confidentiality: reviewers must not share, use, or disclose confidential manuscripts or grant applications; conflicts of interest must be disclosed and reviewers should recuse if conflicted.

  • Whistleblower protections: individuals who report suspected misconduct in good faith are protected from retaliation; institutions must have policies for handling allegations confidentially and fairly.